Physical Activity for Reduction of Recurrence Rate After Adjuvant Chemotherapy for Localised Colorectal Carcinoma
NCT ID: NCT01210313
Last Updated: 2024-09-19
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
30 participants
OBSERVATIONAL
2010-10-31
2013-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
* increase of physical conversation
* Quality of Life (optional)
* vascular and metabolic effects
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
8 Weeks vs 12 Weeks Physical Exercise Programmes in Colorectal Cancer Patients
NCT07307690
Motivational Interviewing to Increase Physical Activity Behaviour in Cancer Patients
NCT03210129
Remote Exercise Maintenance With Health Coaching for Cancer Survivors
NCT04751305
Exercise Program During Chemotherapy in Metastatic Colorectal Cancer
NCT03111823
Physical Activity Intervention for Older Patients During Chemotherapy for Colorectal Cancer
NCT02191969
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Physical exercise
No treatment, only physical examinations accompanying physical exercise
Physical exercise
Defined exercise program
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Physical exercise
Defined exercise program
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* 4-16 weeks after the end of an adjuvant chemotherapy
* ECOG 0,1
* Age \> 18 years
* adequate liver-, nephro- and hemogram parameters
* physical eligibility
Exclusion Criteria
* evidence of local recurrence or distant metastases
* non-compliance of subject
* other malignancy within the last 5 years (except: skin basalioma, cervix carcinoma in situ)
* clinically significant cardiovascular diseases
* treatment with beta blocker without possibility of adjustment
* left bundle-branch block
* simultaneous chemotherapy or radiotherapy
* pregnancy
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Austrian Breast & Colorectal Cancer Study Group
NETWORK
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Josef Thaler, MD
Role: STUDY_CHAIR
Austrian Breast & Colorectal Cancer Study Group
Michael Fridrik, MD
Role: STUDY_CHAIR
Austrian Breast & Colorectal Cancer Study Group
Alfred Fridrik, MD
Role: STUDY_CHAIR
Austrian Breast & Colorectal Cancer Study Group
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hospital BHB St. Veit/Glan, Surgery
Saint Veit A. D. Glan, Carinthia, Austria
Medical University Innsbruck, Internal Medicine
Innsbruck, Tyrol, Austria
District Hospital Kufstein
Kufstein, Tyrol, Austria
AKH Linz
Linz, Upper Austria, Austria
Klinikum Wels-Grieskirchen
Wels, Upper Austria, Austria
State Hospital Rankweil
Rankweil, Vorarlberg, Austria
Paracelsus Medical University Salzburg-Oncology, Coop. Group
Salzburg, , Austria
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Meyerhardt JA, Giovannucci EL, Holmes MD, Chan AT, Chan JA, Colditz GA, Fuchs CS. Physical activity and survival after colorectal cancer diagnosis. J Clin Oncol. 2006 Aug 1;24(22):3527-34. doi: 10.1200/JCO.2006.06.0855. Epub 2006 Jul 5.
Meyerhardt JA, Heseltine D, Niedzwiecki D, Hollis D, Saltz LB, Mayer RJ, Thomas J, Nelson H, Whittom R, Hantel A, Schilsky RL, Fuchs CS. Impact of physical activity on cancer recurrence and survival in patients with stage III colon cancer: findings from CALGB 89803. J Clin Oncol. 2006 Aug 1;24(22):3535-41. doi: 10.1200/JCO.2006.06.0863. Epub 2006 Jul 5.
Holmes MD, Chen WY, Feskanich D, Kroenke CH, Colditz GA. Physical activity and survival after breast cancer diagnosis. JAMA. 2005 May 25;293(20):2479-86. doi: 10.1001/jama.293.20.2479.
Demark-Wahnefried W. Cancer survival: time to get moving? Data accumulate suggesting a link between physical activity and cancer survival. J Clin Oncol. 2006 Aug 1;24(22):3517-8. doi: 10.1200/JCO.2006.06.6548. Epub 2006 Jul 5. No abstract available.
Jackson AS, Pollock ML. Generalized equations for predicting body density of men. Br J Nutr. 1978 Nov;40(3):497-504. doi: 10.1079/bjn19780152.
Hoeger W, Hoeger S. Principles and Labs for Physical Fitness. Morton Publishing Company, first edition 1999
O'Donovan G, Owen A, Bird SR, Kearney EM, Nevill AM, Jones DW, Woolf-May K. Changes in cardiorespiratory fitness and coronary heart disease risk factors following 24 wk of moderate- or high-intensity exercise of equal energy cost. J Appl Physiol (1985). 2005 May;98(5):1619-25. doi: 10.1152/japplphysiol.01310.2004. Epub 2005 Jan 7.
Haber Paul. Leitfaden zur medizinischen Trainingsberatung - Rehabilitation bis Leistungssport. 3. Auflage 2009; Springer Wien New York
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
EXERCISE
Identifier Type: OTHER
Identifier Source: secondary_id
ABCSG C07
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.